Home Carbonyls 3,5-Diethoxycarbonyl-1,4-dihydro-2,4,6-collidine

3,5-Diethoxycarbonyl-1,4-dihydro-2,4,6-collidine

CAS No.:
632-93-9
Catalog Number:
AG003PF3
Molecular Formula:
C14H21NO4
Molecular Weight:
267.3208
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
>98.0%(GC)
1 week
United States
$56
- +
10g
≥98%
1 week
United States
$91
- +
25g
≥98%
1 week
United States
$139
- +
50g
≥98%
1 week
United States
$214
- +
Product Description
Catalog Number:
AG003PF3
Chemical Name:
3,5-Diethoxycarbonyl-1,4-dihydro-2,4,6-collidine
CAS Number:
632-93-9
Molecular Formula:
C14H21NO4
Molecular Weight:
267.3208
MDL Number:
MFCD00005950
IUPAC Name:
diethyl 2,4,6-trimethyl-1,4-dihydropyridine-3,5-dicarboxylate
InChI:
InChI=1S/C14H21NO4/c1-6-18-13(16)11-8(3)12(14(17)19-7-2)10(5)15-9(11)4/h8,15H,6-7H2,1-5H3
InChI Key:
CDVAIHNNWWJFJW-UHFFFAOYSA-N
SMILES:
CCOC(=O)C1=C(C)NC(=C(C1C)C(=O)OCC)C
EC Number:
211-188-0
Properties
Complexity:
408  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
267.147g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
267.325g/mol
Monoisotopic Mass:
267.147g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
64.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.2  
Literature
Title Journal
Upregulation of hydroxysteroid sulfotransferase 2B1b promotes hepatic oval cell proliferation by modulating oxysterol-induced LXR activation in a mouse model of liver injury. Archives of toxicology 20170101
Wnt/β-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3. The Journal of biological chemistry 20130614
4-Isoxazolyl-1,4-dihydropyridines exhibit binding at the multidrug-resistance transporter. Bioorganic & medicinal chemistry 20121115
Flow cytometric evaluation of the effects of 3-bromopyruvate (3BP) and dichloracetate (DCA) on THP-1 cells: a multiparameter analysis. Journal of bioenergetics and biomembranes 20120201
Effect of disease progression on liver apparent diffusion coefficient and T2 values in a murine model of hepatic fibrosis at 11.7 Tesla MRI. Journal of magnetic resonance imaging : JMRI 20120101
Reactive oxygen species are produced at low glucose and contribute to the activation of AMPK in insulin-secreting cells. Free radical biology & medicine 20120101
Genetic abolishment of hepatocyte proliferation activates hepatic stem cells. PloS one 20120101
Deficiency in the inner mitochondrial membrane peptidase 2-like (Immp21) gene increases ischemic brain damage and impairs mitochondrial function. Neurobiology of disease 20111201
How porphyrinogenic drugs modeling acute porphyria impair the hormonal status that regulates glucose metabolism. Their relevance in the onset of this disease. Toxicology 20111128
Nuclear receptor CAR (NR1I3) is essential for DDC-induced liver injury and oval cell proliferation in mouse liver. Laboratory investigation; a journal of technical methods and pathology 20111101
Intestinal involvement during 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced chronic liver injury in a mouse model. Journal of pediatric surgery 20110801
Evaluation of different perfusion durations in direct hemoperfusion with polymyxin B-immobilized fiber column therapy for acute exacerbation of interstitial pneumonias. Blood purification 20110101
Hemoperfusion treatment in a septic shock patient with autosomal dominant polycystic kidney disease and increased HMGB1 protein levels. Blood purification 20110101
Early increases in transglutaminase activity and polyamine levels in a Mallory-Denk body mouse model. Toxicology letters 20101130
Disparate cellular basis of improved liver repair in beta-catenin-overexpressing mice after long-term exposure to 3,5-diethoxycarbonyl-1,4-dihydrocollidine. The American journal of pathology 20101001
Dynamics of intracellular superoxide and NO content in human endotheliocytes and carcinoma cells after treatment with NO synthase inhibitors. Bulletin of experimental biology and medicine 20100701
Heme synthesis increases artemisinin-induced radical formation and cytotoxicity that can be suppressed by superoxide scavengers. Chemico-biological interactions 20100607
Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis. Hepatology (Baltimore, Md.) 20100601
On the use of fluorescence probes for detecting reactive oxygen and nitrogen species associated with photodynamic therapy. Journal of biomedical optics 20100101
Time-related alterations of superoxide radical levels in diverse organs of bile duct-ligated rats. Free radical research 20090901
Attenuation of neuronal degeneration in thioredoxin-1 overexpressing mice after mild focal ischemia. Brain research 20090526
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free radical biology & medicine 20090501
Inducible expression of Wnt genes during adult hepatic stem/progenitor cell response. FEBS letters 20090218
'Toxic memory' via chaperone modification is a potential mechanism for rapid Mallory-Denk body reinduction. Hepatology (Baltimore, Md.) 20080901
The genetic background modulates susceptibility to mouse liver Mallory-Denk body formation and liver injury. Hepatology (Baltimore, Md.) 20080901
Quantification of superoxide radical in the brain of rats with experimentally induced obstructive jaundice. Neurochemical research 20080601
Effect of diazoxide on flavoprotein oxidation and reactive oxygen species generation during ischemia-reperfusion: a study on Langendorff-perfused rat hearts using optic fibers. American journal of physiology. Heart and circulatory physiology 20080501
Deletion of the Met tyrosine kinase in liver progenitor oval cells increases sensitivity to apoptosis in vitro. The American journal of pathology 20080501
Hepatic alteration of tryptophan metabolism in an acute porphyria model Its relation with gluconeogenic blockage. Biochemical pharmacology 20080201
S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology (Baltimore, Md.) 20080201
Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology (Baltimore, Md.) 20080101
Hepatotoxin-induced changes in the adult murine liver promote MYC-induced tumorigenesis. PloS one 20080101
Superoxide radical formation in diverse organs of rats with experimentally induced obstructive jaundice. Redox report : communications in free radical research 20080101
Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology 20071101
A CD133-expressing murine liver oval cell population with bilineage potential. Stem cells (Dayton, Ohio) 20071001
A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. The American journal of pathology 20070801
Characterization of the physiological turnover of native and inactivated cytochromes P450 3A in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97? Biochemistry 20070703
Streptozotocin-induced diabetes can be reversed by hepatic oval cell activation through hepatic transdifferentiation and pancreatic islet regeneration. Laboratory investigation; a journal of technical methods and pathology 20070701
Superoxide signaling mediates N-acetyl-L-cysteine-induced G1 arrest: regulatory role of cyclin D1 and manganese superoxide dismutase. Cancer research 20070701
Heat shock protein 90 modulates endothelial nitric oxide synthase activity and vascular reactivity in the newborn piglet pulmonary circulation. American journal of physiology. Lung cellular and molecular physiology 20070601
Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Hepatology (Baltimore, Md.) 20070101
Concomitant real-time monitoring of intracellular reactive oxygen species and mitochondrial membrane potential in individual living promonocytic cells. Journal of immunological methods 20061020
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension (Dallas, Tex. : 1979) 20061001
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Pharmacologic transglutaminase inhibition attenuates drug-primed liver hypertrophy but not Mallory body formation. FEBS letters 20060417
Mallory body forming cells express the preneoplastic hepatocyte phenotype. Experimental and molecular pathology 20060401
Nimodipine selectively stimulates beta-amyloid 1-42 secretion by a mechanism independent of calcium influx blockage. Neurobiology of aging 20060201
[Antioxidant activity of inhibitors of free radical reactions in the dressing materials for wound healing]. Biomeditsinskaia khimiia 20060101
Response of glucose metabolism enzymes in an acute porphyria model. Role of reactive oxygen species. Toxicology 20051201
Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo. Cancer letters 20050808
The role of laminin-integrin signaling in triggering MB formation. An in vivo and in vitro study. Experimental and molecular pathology 20050801
Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World journal of gastroenterology 20050721
Hepatic porphyria induced by the herbicide tralkoxydim in small mammals is species-specific. Environmental toxicology and chemistry 20050201
Inhibitory effect of pranidipine on N-type voltage-dependent Ca2+ channels in mice. Neuroscience letters 20040826
The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation. Experimental and molecular pathology 20040201
Neural trans-differentiation potential of hepatic oval cells in the neonatal mouse brain. Experimental neurology 20030801
Bile acid-induced Mallory body formation in drug-primed mouse liver. The American journal of pathology 20021201
Effects of the porphyrinogenic compounds hexachlorobenzene and 3,5-diethoxycarbonyl-1,4-dihydrocollidine on polyamine metabolism. Toxicology 20020715
Mallory body--a disease-associated type of sequestosome. Hepatology (Baltimore, Md.) 20020501
[Effects of natural (zinc, vitamin E) and synthetic (diludin) antioxidants on the intestinal permeability in chicks with vitamin A deficiency]. Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20020501
Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation. Journal of hepatology 20010501
Pharmacological intervention with platelet phospholipase A2. Bratislavske lekarske listy 20010101
Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. The American journal of pathology 20000401
Altered microtubule-associated tau messenger RNA isoform expression in livers of griseofulvin- and 3,5-diethoxycarbonyl-1, 4-dihydrocollidine-treated mice. Hepatology (Baltimore, Md.) 19990301
Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products. Hepatology (Baltimore, Md.) 19960701
Properties